Indisetron

Drug Profile

Indisetron

Alternative Names: N-3389; Sinseron

Latest Information Update: 31 Jul 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nisshin Pharma
  • Developer Kyorin Pharmaceutical
  • Class Antiemetics; Organic bridged compounds; Pyrazoles; Small molecules
  • Mechanism of Action Serotonin 3 receptor antagonists; Serotonin 4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Nausea and vomiting

Most Recent Events

  • 20 Sep 2004 Launched for Nausea and vomiting in Japan (PO)
  • 26 Aug 2004 Nisshin formed a cooperative sales agreement with Yakult Honsha for indisetron
  • 11 Sep 2000 Phase-II clinical trials for Nausea and vomiting in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top